Leuthold Group, LLC Amgen Inc Transaction History

Leuthold Group, LLC

$885 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $6.11 Million - $6.78 Million	-26,166 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $537,244 - $626,070	-2,421 Reduced 8.47%	26,166 $6.51 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $340,798 - $405,830	-1,575 Reduced 5.22%	28,587 $6.57 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $139,616 - $155,265	-595 Reduced 1.93%	30,162 $7.67 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $152,511 - $187,152	-771 Reduced 2.45%	30,757 $7.25 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $423,708 - $561,952	-2,325 Reduced 6.87%	31,528 $6.39 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $186,371 - $239,552	-985 Reduced 2.83%	33,853 $8.16 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2 Million - $2.4 Million	11,484 Added 49.17%	34,838 $6.74 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $253,717 - $297,414	-1,522 Reduced 6.12%	23,354 $4.3 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $1.74 Million - $1.97 Million	9,644 Added 63.31%	24,876 $4.73 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $324,509 - $378,806	-1,819 Reduced 10.67%	15,232 $2.97 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $3.16 Million - $3.56 Million	17,051 New	17,051 $3.54 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $7.34 Million - $8.58 Million	-43,344 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.58 Million - $1.77 Million	9,390 Added 27.66%	43,344 $7.54 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1,171 - $1,337	7 Added 0.02%	33,954 $6.33 Million
Q2 2017 Aug 14, 2017	BUY	N/A	33,947	33,947 $5.85 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leuthold Group, LLC with notifications on news.

Account